Nan Chen

1.7k total citations
57 papers, 624 citations indexed

About

Nan Chen is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Nan Chen has authored 57 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Nan Chen's work include Colorectal Cancer Treatments and Studies (9 papers), Colorectal Cancer Surgical Treatments (7 papers) and Colorectal and Anal Carcinomas (7 papers). Nan Chen is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Colorectal Cancer Surgical Treatments (7 papers) and Colorectal and Anal Carcinomas (7 papers). Nan Chen collaborates with scholars based in China, United States and Canada. Nan Chen's co-authors include Yuanmeng Jin, John Cijiang He, Peter Y. Chuang, Vivette D. D’Agati, Hal Drakesmith, Xiao‐Ning Xu, Alain Townsend, Gavin Screaton, Ying Fan and Edward Y. Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Nan Chen

49 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Chen China 13 228 128 115 79 72 57 624
Kishor Devalaraja‐Narashimha United States 10 293 1.3× 118 0.9× 137 1.2× 104 1.3× 73 1.0× 15 625
Jianhao Peng China 14 266 1.2× 48 0.4× 91 0.8× 88 1.1× 134 1.9× 29 884
Roman D. Bülow Germany 12 229 1.0× 207 1.6× 68 0.6× 136 1.7× 50 0.7× 31 762
Tianbo Jin China 16 374 1.6× 55 0.4× 199 1.7× 84 1.1× 130 1.8× 95 882
Fajuan Cheng China 16 220 1.0× 138 1.1× 47 0.4× 82 1.0× 164 2.3× 33 561
Kristin Werner Germany 13 270 1.2× 122 1.0× 283 2.5× 69 0.9× 67 0.9× 22 755
Zongyu Zheng United States 17 404 1.8× 222 1.7× 87 0.8× 80 1.0× 163 2.3× 27 830
Genyang Cheng China 15 206 0.9× 192 1.5× 38 0.3× 73 0.9× 67 0.9× 40 578
Léa Guyonnet France 11 187 0.8× 144 1.1× 31 0.3× 43 0.5× 97 1.3× 19 526
Tatsiana Castor Germany 13 163 0.7× 128 1.0× 24 0.2× 60 0.8× 63 0.9× 27 496

Countries citing papers authored by Nan Chen

Since Specialization
Citations

This map shows the geographic impact of Nan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Chen more than expected).

Fields of papers citing papers by Nan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Chen. The network helps show where Nan Chen may publish in the future.

Co-authorship network of co-authors of Nan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Chen. A scholar is included among the top collaborators of Nan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Chen. Nan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Nan, Margarite D. Matossian, Murtuza Rampurwala, et al.. (2025). A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. Breast Cancer Research and Treatment. 211(1). 111–119. 1 indexed citations
2.
Li, Xin, Nan Chen, Zhaoya Gao, et al.. (2025). HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAFV600E-mutant microsatellite stable colorectal cancer. Journal for ImmunoTherapy of Cancer. 13(1). e010460–e010460. 4 indexed citations
3.
4.
Wang, Kongxiang, Shaohua Liu, Dan Huang, et al.. (2024). Onset age moderates the associations between neutrophil-to-lymphocyte ratio and clinical symptoms in first-episode patients with schizophrenia. SHILAP Revista de lepidopterología. 10(1). 110–110. 1 indexed citations
5.
Fan, Weiguo, et al.. (2024). Decoupling analysis of economic development and human well-being: A case study of the Qinghai-Xizang Plateau, China. PLoS ONE. 19(10). e0312041–e0312041. 1 indexed citations
6.
Chen, Xuehua, Nan Chen, Xiaohong Chen, et al.. (2024). Development of a PCR assay for detection and identification of Eimeria spp. in cattle. Veterinary Parasitology. 332. 110315–110315.
7.
Li, Yingjie, Nan Chen, Xinzhi Liu, et al.. (2024). Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status. Diseases of the Colon & Rectum. 67(11). 1413–1422. 7 indexed citations
8.
Peng, Haoxin, Jiajia Yuan, Xiangrong Wu, et al.. (2024). Single‐cell characterization of differentiation trajectories and drug resistance features in gastric cancer with peritoneal metastasis. Clinical and Translational Medicine. 14(10). e70054–e70054. 11 indexed citations
9.
10.
Chen, Nan, Dongsheng Tu, Stephanie Yasmin Brule, et al.. (2023). Predictive and prognostic features of metastatic colorectal cancer arising from the transverse colon: A pooled analysis of the CCTG/AGITG CO.17 and CO.20 randomized trials.. Journal of Clinical Oncology. 41(4_suppl). 124–124. 1 indexed citations
11.
Li, Yingjie, Xinzhi Liu, Yunfeng Yao, et al.. (2023). Efficacy and safety of preoperative immunotherapy in patients with mismatch repair-deficient or microsatellite instability-high gastrointestinal malignancies. World Journal of Gastrointestinal Surgery. 15(2). 222–233. 8 indexed citations
12.
Chen, Nan, et al.. (2023). Case report: Oxaliplatin-induced idiopathic non-cirrhotic portal hypertension: a case report and literature review. Frontiers in Medicine. 10. 1285064–1285064. 1 indexed citations
13.
Chen, Nan, Rita Nanda, Frederick M. Howard, et al.. (2023). Abstract P5-03-18: Co-occurring alterations in PALB2 germline carriers identified by liquid biopsy in patients with advanced breast cancer. Cancer Research. 83(5_Supplement). P5–3.
14.
Chen, Nan, et al.. (2023). UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer. Cancers. 15(9). 2502–2502. 6 indexed citations
15.
Chen, Nan, et al.. (2022). Long-term follow-up of HER2 overexpression in patients with rectal cancer after preoperative radiotherapy: A prospective cohort study. World Journal of Gastrointestinal Oncology. 14(10). 2048–2060. 1 indexed citations
16.
Chen, Nan, Shan Song, Zhifen Yang, et al.. (2021). ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy. Journal of Diabetes and its Complications. 35(12). 108050–108050. 12 indexed citations
17.
Zhao, Feng, Jun‐yi Zhu, Adam Richman, et al.. (2019). Mutations in NUP160 Are Implicated in Steroid-Resistant Nephrotic Syndrome. Journal of the American Society of Nephrology. 30(5). 840–853. 26 indexed citations
18.
19.
Jin, Yuanmeng, Peter Y. Chuang, Ying Fan, et al.. (2012). A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nature Medicine. 18(4). 580–588. 123 indexed citations
20.
Drakesmith, Hal, et al.. (2005). HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proceedings of the National Academy of Sciences. 102(31). 11017–11022. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kishor Devalaraja‐Narashimha Breakdown of academic impact, for papers by Jianhao Peng Breakdown of academic impact, for papers by Roman D. Bülow Breakdown of academic impact, for papers by Tianbo Jin Breakdown of academic impact, for papers by Fajuan Cheng Breakdown of academic impact, for papers by Kristin Werner Breakdown of academic impact, for papers by Zongyu Zheng Breakdown of academic impact, for papers by Genyang Cheng Breakdown of academic impact, for papers by Léa Guyonnet Breakdown of academic impact, for papers by Tatsiana Castor
Rankless by CCL
2026